Clinical Trial Update: Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on Bronchoscopic Thermal Vapor Ablation (BTVA) for lung volume reduction in emphysema/COPD. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• Bronchoscopic Thermal Vapor Ablation (BTVA)

Snippet

Sponsor: Uptake Medical Corp | Conditions: Emphysema, Chronic Obstructive Pulmonary Disease | Phase 1 | Status: COMPLETED